GlaxoSmithKline PLC Stock Forecast - Triple Exponential Smoothing

GSK Stock  USD 42.87  0.12  0.28%   
The Triple Exponential Smoothing forecasted value of GlaxoSmithKline PLC ADR on the next trading day is expected to be 42.72 with a mean absolute deviation of  0.34  and the sum of the absolute errors of 20.16. GlaxoSmithKline Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC stock prices and determine the direction of GlaxoSmithKline PLC ADR's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of GlaxoSmithKline PLC's historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Historical Fundamental Analysis of GlaxoSmithKline PLC to cross-verify your projections.
  
Most investors in GlaxoSmithKline PLC cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the GlaxoSmithKline PLC's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets GlaxoSmithKline PLC's price structures and extracts relationships that further increase the generated results' accuracy.
Triple exponential smoothing for GlaxoSmithKline PLC - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When GlaxoSmithKline PLC prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in GlaxoSmithKline PLC price movement. However, neither of these exponential smoothing models address any seasonality of GlaxoSmithKline PLC ADR.

GlaxoSmithKline PLC Triple Exponential Smoothing Price Forecast For the 29th of March

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of GlaxoSmithKline PLC ADR on the next trading day is expected to be 43.07 with a mean absolute deviation of 0.34, mean absolute percentage error of 0.20, and the sum of the absolute errors of 20.14.
Please note that although there have been many attempts to predict GlaxoSmithKline Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that GlaxoSmithKline PLC's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

GlaxoSmithKline PLC Stock Forecast Pattern

Backtest GlaxoSmithKline PLCGlaxoSmithKline PLC Price PredictionBuy or Sell Advice 

GlaxoSmithKline PLC Forecasted Value

In the context of forecasting GlaxoSmithKline PLC's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. GlaxoSmithKline PLC's downside and upside margins for the forecasting period are 42.09 and 44.06, respectively. We have considered GlaxoSmithKline PLC's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
42.87
43.07
Expected Value
44.06
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of GlaxoSmithKline PLC stock data series using in forecasting. Note that when a statistical model is used to represent GlaxoSmithKline PLC stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors 0.0487
MADMean absolute deviation0.3413
MAPEMean absolute percentage error0.0083
SAESum of the absolute errors20.1367
As with simple exponential smoothing, in triple exponential smoothing models past GlaxoSmithKline PLC observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older GlaxoSmithKline PLC ADR observations.

Predictive Modules for GlaxoSmithKline PLC

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GlaxoSmithKline PLC ADR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GlaxoSmithKline PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
41.9242.9043.88
Details
Intrinsic
Valuation
LowRealHigh
38.6344.3845.36
Details
Bollinger
Band Projection (param)
LowMiddleHigh
42.7342.9043.07
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as GlaxoSmithKline PLC. Your research has to be compared to or analyzed against GlaxoSmithKline PLC's peers to derive any actionable benefits. When done correctly, GlaxoSmithKline PLC's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in GlaxoSmithKline PLC ADR.

Other Forecasting Options for GlaxoSmithKline PLC

For every potential investor in GlaxoSmithKline, whether a beginner or expert, GlaxoSmithKline PLC's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. GlaxoSmithKline Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in GlaxoSmithKline. Basic forecasting techniques help filter out the noise by identifying GlaxoSmithKline PLC's price trends.

GlaxoSmithKline PLC Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GlaxoSmithKline PLC stock to make a market-neutral strategy. Peer analysis of GlaxoSmithKline PLC could also be used in its relative valuation, which is a method of valuing GlaxoSmithKline PLC by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

GlaxoSmithKline PLC ADR Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of GlaxoSmithKline PLC's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of GlaxoSmithKline PLC's current price.

GlaxoSmithKline PLC Market Strength Events

Market strength indicators help investors to evaluate how GlaxoSmithKline PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GlaxoSmithKline PLC shares will generate the highest return on investment. By undertsting and applying GlaxoSmithKline PLC stock market strength indicators, traders can identify GlaxoSmithKline PLC ADR entry and exit signals to maximize returns.

GlaxoSmithKline PLC Risk Indicators

The analysis of GlaxoSmithKline PLC's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in GlaxoSmithKline PLC's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting glaxosmithkline stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GlaxoSmithKline PLC in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GlaxoSmithKline PLC's short interest history, or implied volatility extrapolated from GlaxoSmithKline PLC options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether GlaxoSmithKline PLC ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlaxoSmithKline Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glaxosmithkline Plc Adr Stock. Highlighted below are key reports to facilitate an investment decision about Glaxosmithkline Plc Adr Stock:
Check out Historical Fundamental Analysis of GlaxoSmithKline PLC to cross-verify your projections.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for GlaxoSmithKline Stock analysis

When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.